Kursprognose für Oncolytics Biotech Inc (ONCY)ONCYOncolytics Biotech Inc

Alphio's ONCY stock price prediction model matches the current Oncolytics Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.43 (-1.17%). The 1-week path is $0.44 (-0.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Oncolytics Biotech Inc is not a good buy right now due to its current price of $0.40, which is significantly below its 52-week high of $1.30, indicating a substantial decline in value. Additionally, the company's RSI is at a very low 12.234, suggesting it is oversold and may continue to face downward pressure. The forward P/E ratio of 45.45 indicates high expectations for future earnings that may not materialize given the company's ongoing losses, with net income consistently negative, such as -12,679,060.40 USD in Q1 2026. The main risk is the company's cash position, which is only $5.49 million, insufficient to sustain operations for the next 12 months, raising doubts about its viability.

Oncolytics Biotech Inc (ONCY) last closed at $0.4394, losing -2.09%. These facts feed the 1-day and 1-week ONCY price prediction above.